Innovating Works

filtrando por convocatoria: HORIZON-HLTH-2022-DISEASE-06-02-two-stage

Mostrando 21 al 25 de 25 resultados
CAPTIVATE: CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Malaria remains a serious health concern worldwide, with P. falciparum considered one of the deadliest human parasites. Yet, the currently a...
2023-11-01 - 2028-04-30 | Financiado
MAGIC: Next-generation models and genetic therapies for rare neuromuscular diseases INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Muscular dystrophies are severe genetic disorders characterised by muscle wasting, impaired mobility and premature death, which to date rema...
2023-06-01 - 2027-05-31 | Financiado
ITHEMYC: Novel immunotherapies for tuberculosis and other mycobacterial diseases STICHTING TUBERCULOSIS VACCINE INITIATIVE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Tuberculosis (TB) remains the leading cause of death due to a single pathogen, Mycobacterium tuberculosis (Mtb; except in 2020-2022, when it...
2023-06-01 - 2027-05-31 | Financiado
WORMVACS2.0: Innovations for vaccines against helminth infections ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Infections with parasitic worms (helminths) continue to cause a massive global health burden. Yet, effective vaccines to enable control and...
2023-09-01 - 2028-08-31 | Financiado
Vax2Muc: NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MO... TECHNISCHE UNIVERSITAET MUENCHEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage To overcome antimicrobial resistance (AMR) compromising global public health, novel strategies to develop next generation vaccines against A...
2023-07-01 - 2028-06-30 | Financiado